INTENSITY THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, stock dividend for the quarter ending 2023-06-30 was $0.00.
- INTENSITY THERAPEUTICS, INC. stock issued during period, value, stock dividend for fiscal 2023 was $0.00.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |